Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Acute Anditody-Mediated Rejection of the Kidney Transplant (CROSBI ID 591092)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Sladoje-Martinović, Branka ; Orlić, Lidija ; Živčić-Ćosić, Stela ; Rački, Sanjin ; Vuksanović-Mikuličić, Sretenka ; Maleta, Ivica ; Bubić, Ivan ; Pavletić-Peršić, Martina Acute Anditody-Mediated Rejection of the Kidney Transplant // Transplantation / Suthanthiran Manikkam (ur.). New York (NY): Lippincott Williams and Wilkins, 2012

Podaci o odgovornosti

Sladoje-Martinović, Branka ; Orlić, Lidija ; Živčić-Ćosić, Stela ; Rački, Sanjin ; Vuksanović-Mikuličić, Sretenka ; Maleta, Ivica ; Bubić, Ivan ; Pavletić-Peršić, Martina

engleski

Acute Anditody-Mediated Rejection of the Kidney Transplant

Introduction: Acute humoral rejection occurs in 20% of renal transplant patients. Its prognosis is worse than when it comes to cellular rejection, and it is refractory to conventional immunosuppressive therapy. C4d deposition in peritubular capillaries of the kidney transplant has shown as a sensitive diagnostic marker of acute antibody mediated rejection, which correlates with the presence of circulating donor specific antibodies. Aim of this work was to demonstrate our experiences with therapy and medical treatment results of kidney transplant patients with antibody mediated acute rejection. Patients and methods: Eight kidney transplant patients in whom the acute humoral rejection appeared have been analyzed, out of which four men and four women. The rejection has been proven by biopsy of the kidney transplant and/or the existence of donor specific antibodies. The average age of the patients was 39±14.3 years. The average duration of hemodialysis treatment was 5.9±5 years. In four patients the primary renal disease was glomerulonephritis, pyelonephritis in two, and endemic nephropathy, as well as nephronophtisis in one patient. All patients were subjected to cadaveric kidney transplantation. Three of them had already been transplanted before. In three patients humoral rejection appeared in a month after the operation (4-18 days), and in other five patients in 1-12 years. Results: Two patients were treated with plasmapheresis and intravenous immunoglobulin dose of 2 g per kg of body weight together in addition to the other means of immunosuppressive therapy. The other six patients were treated only with 2 g per kg of intravenous immunoglobulin together with the other means of immunosuppressive therapy. In seven patients the function of the kidney transplant recovered after the therapy, while in one patient recovery did not occur. Therefore the remaining patient has been subjected to hemodialysis treatment. The average values of serum creatinine (in seven patients) a month after the therapy ranged from 73 µmol/l to 279 µmol/l. In three patients in which the crises appeared during the first month, a complete recovery of kidney transplant function occured. In six months all of the seven patients had stable transplant function. Conclusion: From the above results, a conclusion can be drawn that the acute humoral rejection can be treated efficiently in case it is diagnosed on time and treated adequately.

kidney transplantation; antibody-mediated rejection; intravenous immunoglobulins

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2012.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Transplantation

Suthanthiran Manikkam

New York (NY): Lippincott Williams and Wilkins

Podaci o skupu

24th International Congress of The Transplantation Society

poster

15.07.2012-19.07.2012

Berlin, Njemačka

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti